Protara Therapeutics Inc.

TARA | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.81

+$0.30 (+8.55%)

Sep 22, 2026, 10:40 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $197.28M

Enterprise Value $182.95M

Beta 1.49

Average Volume 599.05K

Shares Outstanding (Diluted) 61.01M

Shares Change YoY 44.32%

Institutional Ownership 79.18%

Exchange NASDAQ

ISIN US74365U1079

Price Performance

Price Change 1M -8.4%

Price Change 3M -12.3%

Price Change 6M -33.9%

Price Change YTD -34.8%

Price Change 1Y -4.4%

Price Change 3Y 104.1%

Price Change 5Y -51.5%

1M CAGR (ann.) -14.8%

1Y CAGR (ann.) 9.3%

5Y CAGR (ann.) -14.3%

All-Time CAGR -32.8%

Valuation

PE Ratio -2.58

Forward PE N/A

PEG Ratio -0.15

Forward PEG -0.14

PS Ratio N/A

Forward PS 169.10

PB Ratio 1.22

P/FCF Ratio -3.03

P/Adj. FCF Ratio -2.82

P/OCF Ratio -3.31

EV/Sales N/A

EV/EBIT -2.61

EV/EBITDA -2.63

EV/FCF -2.81

Earnings Yield -38.8%

FCF Yield -33.0%

Adj. FCF Yield -35.5%

Financial Health

Net Cash $17.08M

Total Debt $2.75M

Cash & Short-Term Investments $17.08M

Total Assets $176.09M

Current Ratio 10.97

Quick Ratio 10.97

Debt / Equity Ratio 0.02

Debt / EBITDA -0.04

Debt / FCF -0.04

OCF / Debt -23.57

Interest Coverage 0.00

Altman Z-Score 4.88

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -7.4%

Returns

Return on Assets -39.8%

Return on Equity -41.7%

Return on Invested Capital -46.8%

Return on Capital Employed -47.2%

Return on Tangible Assets -39.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 44.5%

EPS CAGR 5Y 27.6%

EPS CAGR 10Y 38.4%

FCF CAGR 3Y -33.2%

FCF CAGR 5Y -20.4%

FCF CAGR 10Y -13.2%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 6

EPS Growth Next 3Y 37.5%

Revenue Growth Next 3Y N/A

Earnings Date Nov 8, 2026

EPS Estimate (next Q) -$0.37

EPS Growth Est (next Q) 19.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $12

Price Target Upside 241.9%

Cash Flow

Operating Cash Flow $-64.8M

Free Cash Flow $-65.16M

Adj. Free Cash Flow $-70M

FCF Per Share -$1.07

OCF Per Share -$1.06

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-90K

Operating Income $-76.79M

EBITDA $-69.67M

Net Income $-70.02M

EPS (Diluted) -$1.36

Revenue / Employee N/A

Profit / Employee $-1.52M

Employees 46